The Best of Canadian Science and Technology
Is it crazy to be betting on BlackBerry (BlackBerry Stock Quote, Chart, News TSX:BB) these days? Actually, no, says portfolio manager John Zechner, … [Read more...] about I like BlackBerry stock. Do I need my head examined?
Medical imaging company Akumin (Akumin Stock Quote, Chart, News TSX:AKU.U) is now dual listed on both the TSX and NASDAQ, a move that should help … [Read more...] about Buy medical imaging stock Akumin for a double, Clarus says
A new 5G enabled BlackBerry (BlackBerry Stock Quote, Chart, News TSX:BB) smartphone is set to hit store shelves in 2021, but for those investors … [Read more...] about A new phone isn’t saving BlackBerry, this investor says
Everyone knows that Shopify (Shopify Stock Quote, Chart, News TSX:SHOP) shareholders have made out like bandits in recent years but the trick will be … [Read more...] about Shopify is due for a pullback, this investor says
Industrial Alliance Securities analyst Chelsea Stellick launched coverage of Appili Therapeutics (Appili Therapeutics Stock Quote, Chart, News … [Read more...] about Appili Therapeutics gets new “Buy” rating at Industrial Alliance
Canadian health tech name WELL Health (WELL Health Stock Quote, Chart, News TSX:WELL) just entered the US telemedicine market, but will the company … [Read more...] about Can WELL Health Technologies take on Teladoc?
After closing on a Colorado acquisition, Beacon Securities analyst Russell Stanley is bumping up his target price on Columbia Care (Columbia Care … [Read more...] about Beacon Securities raises target on Columbia Care to $7.00
The news is bad for Acasti Pharma (Acasti Pharma Stock Quote, Chart, News TSX:ACST), according to Echelon Wealth analyst Douglas Loe, who on Monday … [Read more...] about Sell Acasti Pharma, says Echelon Wealth
There’s likely more upside to come from Neptune Wellness Solutions (Neptune Wellness Solutions Stock Quote, Chart, News TSX:NEPT) after a new deal … [Read more...] about Unilever deal is good for Neptune Wellness, says Echelon
Raymond James analyst Rahul Sarugaser has a few words of caution concerning cannabis play Auxly Cannabis Group (Auxly Cannabis Group Stock Quote, … [Read more...] about Auxly Cannabis is a double over the next year, says Raymond James
